qh-ii-66 has been researched along with Melanoma* in 1 studies
1 other study(ies) available for qh-ii-66 and Melanoma
| Article | Year |
|---|---|
Melanoma Cell Intrinsic GABA
Most patients with metastatic melanoma show variable responses to radiation therapy and do not benefit from immune checkpoint inhibitors. Improved strategies for combination therapy that leverage potential benefits from radiation therapy and immune checkpoint inhibitors are critical.. We analyzed metastatic melanoma tumors in the TCGA cohort for expression of genes coding for subunits of type A γ-aminobutyric acid (GABA) receptor (GABA. Genes coding for subunits of GABA. This study identifies an antitumor strategy combining radiation and/or an immune checkpoint inhibitor with modulation of GABA Topics: Animals; Benzodiazepines; Cell Proliferation; Combined Modality Therapy; Female; Humans; Immune Checkpoint Inhibitors; Melanoma; Membrane Proteins; Mice; Mice, Inbred C57BL; Radiation-Sensitizing Agents; Receptors, GABA-A; T-Lymphocytes | 2021 |